News & Perspective

Dec 22, 2014

Dec 22, 2014
Package of Rapivab (peramivir), a flu drug

FDA approval of peramivir makes IV flu drug available

Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.

Apr 17, 2014

Apr 17, 2014

News Scan for Apr 17, 2014

H5N1, H5N8 updates
New NBSB advisors
Valley fever in TV film crew
Pakistani army fights polio

Jan 07, 2013

Jan 07, 2013

WHO: Many northern countries see swelling flu activity

(CIDRAP News) – Many Northern Hemisphere countries, from North America to temperate Asia, have seen rising flu activity in recent weeks, while cases ebbed or remained scarce in most of the rest of the world, the World Health Organization (WHO) said today.

Nov 19, 2012

Nov 19, 2012

FAO sees signs of decline in H5N1 outbreaks

(CIDRAP News) – The number of reported H5N1 avian influenza outbreaks in poultry and wild birds has decreased since mid 2011 and was down sharply in the second quarter of this year, the United Nations Food and Agriculture Organization (FAO) said in a quarterly update on the ongoing situation.

Jun 15, 2012

Jun 15, 2012

WHO report sums up Northern Hemisphere flu season

(CIDRAP News) – The 2011-12 flu season in most temperate countries of the Northern Hemisphere started later than usual, except for North Africa, and was mild in many countries, the World Health Organization (WHO) said today in a wrap-up report.

May 11, 2012

May 11, 2012

Flu activity at low levels in US, worldwide

(CIDRAP News) – US influenza activity declined overall and in most regions last week, the Centers for Disease Control and Prevention (CDC) reported today, while Northern Hemisphere flu activity in general continued to fall.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»